| 2024-05-03 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 66,756 0.0587% | $74.69 | $4.99M | -19.14% | |
| 2024-01-04 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 15,000 0.0144% | $17.90 | $268,500 | +240.47% | |
| 2023-04-17 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 7,500 0.0098% | $20.00 | $150,000 | -3.46% | |
| 2023-04-12 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 41,544 0.0538% | $18.00 | $747,792 | +5.25% | |
| 2023-04-11 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 56,295 0.0731% | $18.00 | $1.01M | +5.31% | |
| 2023-04-03 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 30,911 0.0404% | $18.00 | $556,398 | +3.39% | |
| 2023-03-30 | Sale | Viking Therapeutics, Inc. VKTX | Chief Financial Officer | 131,029 0.1641% | $17.00 | $2.23M | +3.58% | |
| 2008-02-14 | Sale | Sangamo Therapeutics, Inc. SGMO | VP, Finance & Administration | 5,100 0.0129% | $12.02 | $61,295 | -19.5% | |
| 2008-01-08 | Sale | Sangamo Therapeutics, Inc. SGMO | Vice President, Fin. & Admin. | 5,000 0.0128% | $12.87 | $64,370 | -18.25% | |
| 2007-12-07 | Sale | Sangamo Therapeutics, Inc. SGMO | Vice President, Fin. & Admin. | 5,000 0.013% | $15.80 | $78,995 | -29.53% |